Related references
Note: Only part of the references are listed.Emerging Role of MicroRNAs in mTOR Signaling
Yanjie Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR
Fangyi Huo et al.
BIOTECHNOLOGY LETTERS (2016)
Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma
Zhenhua Zhou et al.
CLINICAL SCIENCE (2016)
MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer
Ying Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion
Jun Huang et al.
ONCOLOGY REPORTS (2016)
RPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF
Motohiro Tsuchiya et al.
RNA BIOLOGY (2016)
MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST
L. K. Zhuang et al.
CELL DEATH & DISEASE (2016)
Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling
Christopher L. Haga et al.
ACS CHEMICAL BIOLOGY (2015)
The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR
Hao-Hui Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
MKP-1 is a target of miR-210 and mediate the negative regulation of miR-210 inhibitor on hypoxic hPASMC proliferation
Youpeng Jin et al.
CELL BIOLOGY INTERNATIONAL (2015)
Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway
M. K. Siu et al.
ONCOGENE (2015)
AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension
Matthias Brock et al.
EUROPEAN HEART JOURNAL (2014)
MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
Yu Hu et al.
PLOS ONE (2014)
The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas
Zhe Bao Wu et al.
BRAIN RESEARCH (2013)
mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects
Elena A. Goncharova
FASEB JOURNAL (2013)
Hypoxia: A master regulator of microRNA biogenesis and activity
Shriram Nallamshetty et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway
Takeshi Iwaya et al.
CARCINOGENESIS (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
MicroRNA regulation of smooth muscle gene expression and phenotype
Hara Kang et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Bone Morphogenetic Protein 4 Promotes Vascular Smooth Muscle Contractility by Activating MicroRNA-21 (miR-21), which Down-regulates Expression of Family of Dedicator of Cytokinesis (DOCK) Proteins
Hara Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells
Ping Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer
Atsushi Uesugi et al.
CANCER RESEARCH (2011)
MicroRNA-100 Regulates Neovascularization by Suppression of Mammalian Target of Rapamycin in Endothelial and Vascular Smooth Muscle Cells
Sebastian Grundmann et al.
CIRCULATION (2011)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Hypoxia Potentiates MicroRNA-Mediated Gene Silencing through Posttranslational Modification of Argonaute2
Connie Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways
C. Oneyama et al.
ONCOGENE (2011)
Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline
Paola Caruso et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
Francesca Fornari et al.
CANCER RESEARCH (2010)
The cellular response to hypoxia: tuning the system with microRNAs
Joseph Loscalzo
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
Stephen Y. Chan et al.
CELL METABOLISM (2009)
Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway
Matthias Brock et al.
CIRCULATION RESEARCH (2009)
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Xin Huang et al.
MOLECULAR CELL (2009)
MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem Cells
Srikumar Sengupta et al.
STEM CELLS (2009)
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms
N. Sommer et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
SL Cai et al.
JOURNAL OF CELL BIOLOGY (2006)
14-3-3β binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin
SD Shumway et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Share Paper
